| Autor: |
Studney D; University of British Columbia, Vancouver, Canada. studney@interchange.ubc.ca |
| Jazyk: |
angličtina |
| Zdroj: |
The Canadian journal of cardiology [Can J Cardiol] 2002 May; Vol. 18 Suppl A, pp. 3A-6A. |
| Abstrakt: |
Diabetes has long been recognized as a risk factor for heart disease. Recent evidence has brought to light complex interactions that seem to influence both the renal and the vascular complications of diabetes. The use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers has been shown to ameliorate renal and cardiac risks in both type 1 and type 2 diabetes to a degree that is disproportionate to blood pressure-lowering effects. The judicious use of these agents can materially improve the prognosis for patients with diabetes. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
